<DOC>
	<DOCNO>NCT02669082</DOCNO>
	<brief_summary>This study explore effect ramelteon 8 mg daily 8 week treatment insomnia patient depression use actigraphy .</brief_summary>
	<brief_title>The Exploratory Study Investigate Effect Ramelteon Insomnia Patients With Major Depressive Disorder Using Actigraphy</brief_title>
	<detailed_description>The drug test study call ramelteon . Ramelteon test treat people insomnia depression . This study look sleep activity participant take ramelteon . The study enroll approximately 30 patient . Participants administer : â€¢ Ramelteon 8 mg Participants ask take 1 tablet orally bedtime . This multi-center study conduct Japan . The overall period participate study 9 week ( Run-in period 1 week treatment period 8 week ) . Participants make multiple visit clinic include final visit 8 week start treatment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>1 . Has difficulty initiate sleep least 3 day per week last 4 week long time inform consent . 2 . Has Diagnostic Statistical Manual Mental Disorders Fifth Edition ( DSM5 ) define depression . 3 . Man woman 20 64 year age , inclusive , time informed consent . 4 . Outpatient . 5 . Meets either follow criterion base 17item Hamilton Rating Scale Depression ( HAMD17 ) start runin period start study treatment period : score 2 `` 6 : Insomnia Early '' , score 1 `` 6 : Insomnia Early '' AND score least 3 total `` 7 : Insomnia Middle '' `` 8 : Insomnia Late '' . 6 . Has total HAMD17 score 16 start runin period start study treatment period . 7 . Under treatment antidepressant agent least 8 week stable dose least 4 week inform consent . 8 . Goes bed routinely daily life ( time bed 21.00 p.m. 1.00 a.m. least 4 day per week ) . 9 . Actigraphy show least 3 day sleep latency 30 minute longer AND total nocturnal sleep time 6.5 hour short day runin period . 10 . In opinion principal investigator investigator , capable understanding content study comply study requirement . 11 . Is capable sign date informed consent form person study procedure . 1 . Has history hypersensitivity ramelteon melatonin . 2 . Has severe liver disorder . 3 . Took ramelteon within 4 week inform consent . 4 . Using insomnia medication ( include investigational drug unapproved drug ) 2 week treatment period . 5 . Shift worker night worker . 6 . Has current past history psychiatric neurological disease depression . 7 . Has HAMD17 score least 1 '' 11 : Suicide '' start runin period start study treatment period , suicide attempt within 24 week runin period . 8 . Pregnant woman , nurse mother , woman plan become pregnant donate egg inform consent , study period within 4 week end study . 9 . Is participate investigational postmarketing clinical trial/study . 10 . For reason , judge appropriate participation study principal investigator investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>